Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients

Krishan Aggarwal, Neil; Beaty, Laurel; D. Bennett, Tellen; E. Carlson, Nichole; B. Davis, Christopher; M. Kwan, Bethany; Mayer, David; C. Ong, Toan; Russell, Seth; Steele, Jeffrey; F. Wogu, Adane; K. Wynia, Matthew; D. Zane, Richard; A. Ginde, Adit

doi:10.1101/2022.04.03.22273360

Public

Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients

Published in medRxiv • Apr 5, 2022

Authors:

Neil Krishan Aggarwal

Laurel Beaty

Tellen D. Bennett

Abstract

Background: It is not known whether sotrovimab, a neutralizing monoclonal antibody (mAb) treatment authorized for early symptomatic COVID-19 patients, is effective against the SARS-CoV-2 Delta variant to prevent progression to severe disease and mortality. Methods: 2021, using electronic health reco...

Subject

Medicine

Propensity score matching

Internal medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!